Pfizer Reaches Settlement Agreement On 10,000 Lawsuits Linking Zantac Medication To Cancer

Published by admin on

Pfizer has agreed to financially settle 10,000 lawsuits which allege that the pharmaceutical company did not disclose to patients that possible cancer risks were associated with its anti-heartburn medication Zantac.
Categories: acid refluxAngela Valadezanti-heartburn medicationBloomberg NewsBoehringer Ingelheimcancer risksCHICAGOcolorectal cancerdrug marketFDAFood and Drug Administrationgeneric versionsGlaxo HoldingsGlaxoSmithKlineGSKheartburnlawsuitsNDMAOAN NewsroompatentPfizerpharmaceutical companiesranitidineSanofiTodays HeadlinestrialulcersZantac

Related Posts

Alvin Bragg

Judge Delays Trump’s Sentencing In Manhattan ‘Hush Money’ Case, Considers Dismissing Charges

A Manhattan judge has postponed Donald Trump’s sentencing for his conviction in his hush-money case and said he’ll consider getting rid of the case entirely after voters elected him to become the next President. 

Alphabet

S&P 500, Dow touch over one-week highs after business activity data

The S&P 500 and the Dow touched over one-week highs after data showed a still robust economy, while small-cap stocks outperformed large-cap indexes.

9th U.S. Circuit Court of Appeals

US Supreme Court tosses case involving securities fraud suit against Facebook

The Supreme Court sidestepped a decision on whether to allow shareholders to proceed with a securities fraud lawsuit accusing Facebook of misleading investors.